LY-2880070
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LY-2880070, covering 2025-08-15 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY2880070 and Gemcitabine in People With Ewing Sarcoma,Ewing-Like Sarcoma, and Desmoplastic Small Round Cell Tumor [Phase 2]